This definition appears very rarely
and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
Samples in periodicals archive:
The primary measure of efficacy was assessed using the self-reporting questionnaire, Inventory of Depressive Symptomatology self-rated version (IDS-SR30), containing 30 items measuring depressive symptoms based on the DSM-IV criteria with regards to frequency and severity of the previous 7 days.
After 8 weeks, change in average, total clinician-rated, 30-item Inventory of Depressive Symptomatology (IDS) score--showed a 21.
Other measures include the Quick Inventory of Depressive Symptomatology (QIDS)  which is available in both clinician-rated and patient-rated formats and the patient-rated Beck Depression Inventory (BDI).
and the Quick Inventory of Depressive Symptomatology (scores of 5.
The investigators defined remission as an exit score of 5 or less on the 16-item Quick Inventory of Depressive Symptomatology Self-Report (QIDS-SR) or an exit score of 7 or less on the 17-item Hamilton Depression Rating Scale (HAM-D) and response as 50% or greater improvement in QIDS-SR score.
Secondary outcomes measures included changes in scores on the self-rated Quick Inventory of Depressive Symptomatology (QIDS-SR) and the Clinical Global Impression Severity Scale (CGI-S).
Nine of 14 patients achieved a clinically meaningful antidepressant response to TMS, as defined by at least a 50% reduction in scores on the Quick Inventory of Depressive Symptomatology (QIDS-16 SR) from an initial mean baseline of 18.
Results from the six week proof-of-concept clinical study of BCI-952 showed that it had a positive clinical impact on depression symptoms with improvements in multiple clinical endpoints of depression including the Clinical Global Impressions Scale for improvement (CGI-I), the Inventory of Depressive Symptoms (IDSC30), the Hamilton Anxiety Scale and the patient-rated Quick Inventory of Depressive Symptomatology (QIDS SR-16) as compared to placebo or buspirone alone.